NCT07407933 2026-04-09A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1/2 Recruiting118 enrolled
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 4 FDA
NCT06128551 2026-02-10Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsRevolution Medicines, Inc.Phase 1/2 Recruiting534 enrolled
NCT06004440 2025-11-13Real World Registry for Use of the Ion Endoluminal SystemIntuitive SurgicalRecruiting3,000 enrolled
NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled